Home Cart Sign in  
Chemical Structure| 52-52-8 Chemical Structure| 52-52-8

Structure of Cycloleucine
CAS No.: 52-52-8

Chemical Structure| 52-52-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Cycloleucine is a specific inhibitor of S-adenosylmethionine-mediated methylation and also an antagonist at the glycine modulatory site of the NMDA receptor, with a Ki of 600 μM. Additionally, It is a competitive inhibitor of ATP in vitro, possessing anxiolytic and cell-inhibitory effects.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Cycloleucine

CAS No. :52-52-8
Formula : C6H11NO2
M.W : 129.16
SMILES Code : O=C(C1(CCCC1)N)O
MDL No. :MFCD00001381
InChI Key :NILQLFBWTXNUOE-UHFFFAOYSA-N
Pubchem ID :2901

Safety of Cycloleucine

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H312-H315-H319-H332-H335
Precautionary Statements:P262-P280-P301+P310-P304+P340-P305+P351+P338-P310

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
U87MG cells 40 μM 24 h Inhibited m6A modification, reduced SLC7A11 protein level Cell Death Dis. 2022 Jan 21;13(1):73
Chicken primary myoblast cells 10 mM, 20 mM, 30 mM 24 h To investigate the effect of Cycloleucine on the proliferation and differentiation of chicken primary myoblast cells. Results showed that Cycloleucine significantly reduced m6A levels, inhibited myoblast proliferation and myotube formation. Poult Sci. 2022 Dec;101(12):102219
chicken myoblasts 10 mM 24 h To investigate the effect of m6A modification on myoblast proliferation and differentiation; results showed that cycloleucine significantly downregulated the m6A modification level of myoblasts and inhibited their proliferation and differentiation. Poult Sci. 2024 Dec;103(12):104292
bone marrow stromal cells (BMSCs) 500 µg/mL 3 days To investigate the effect of Cycloleucine on osteogenic differentiation of BMSCs, results showed that Cycloleucine blocked the corin-mediated promotion effect Int J Oral Sci. 2024 May 23;16(1):42
U-2 OS cells 20 mM 24 h To decrease SAM levels, inhibit MTORC1 activity, and activate autophagy. Autophagy. 2022 Feb;18(2):309-319
MEF cells 20 mM 24 h To decrease SAM levels and activate autophagy. Autophagy. 2022 Feb;18(2):309-319
U-2 OS cells 20 mM 24 h To explore the effect of SAM and SAH on autophagy. cLEU treatment decreased SAM levels, leading to MTORC1 inhibition, as indicated by decreased phosphorylation of ULK1, RPS6KB1, and EIF4EBP1, along with increased LC3-II and decreased LC3-I. Autophagy. 2022 Feb;18(2):309-319

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

7.74mL

1.55mL

0.77mL

38.71mL

7.74mL

3.87mL

77.42mL

15.48mL

7.74mL

Dissolving Methods
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories